Page last updated: 2024-12-06

farnesal

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Cross-References

ID SourceID
PubMed CID5280598
CHEMBL ID3120646
CHEBI ID24012
CHEBI ID15894
MeSH IDM0224512

Synonyms (46)

Synonym
3,7,11-trimethyldodeca-2,6,10-trienal
CHEBI:24012
3,7,11-trimethyl-2,6,10-dodecatrienal
2,6,10-dodecatrienal, 3,7,11-trimethyl-
(2-trans,6-trans)-farnesal
CHEBI:15894 ,
trans-farnesal
(2-trans,6-trans)-3,7,11-trimethyldodeca-2,6,10-trienal
trans,trans-2,6-farnesal
(e,e)-3,7,11-trimethyl-2,6,10-dodecatrienal
e,e-farnesal
(2e,6e)-3,7,11-trimethyldodeca-2,6,10-trienal
2,6,10-dodecatrienal, 3,7,11-trimethyl-, (e,e)-
19317-11-4
502-67-0
farnesal
trans,trans-farnesal
2-trans,6-trans-farnesal
(2e,6e)-3,7,11-trimethyl-2,6,10-dodecatrienal
C03461
(2e,6e)-farnesal
2-trans-6-trans-farnesal
LMPR0103010012
farnesal, (2e,6e)-
unii-g4e58106ew
2,6,10-dodecatrienal, 3,7,11-trimethyl-, (2e,6e)-
g4e58106ew ,
einecs 242-957-9
unii-r265g157tq
ai3-32959
r265g157tq ,
(2e,6e)-3,7,11-trimethyl-dodeca-2,6,10-trienal
CHEMBL3120646
fema no. 4019, (2e,6e)-
farnesal, pract.
(e,e)-3,7,11-trimethyl-2,6,10-dodecatrienaldehyde
(2e,6e)-3,7,11-trimethyl-2,6,10-dodecatrien-1-al
(2e,6e)-3,7,11-trimethyl-2,6,10-dodecatrienal #
3,7,11-trimethyl-dodeca-2,6,10-trienal
AKOS024263035
(e,e)-farnesal
mfcd00038089
J-012508
DTXSID60880981
Q27098285
AMY13370
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (2)

ClassDescription
farnesal
polyprenalAny enal having a polyprenyl chain.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Pathways (3)

PathwayProteinsCompounds
juvenile hormone III biosynthesis I017
farnesylcysteine salvage pathway215
juvenile hormone III biosynthesis I422
juvenile hormone III biosynthesis II116

Bioassays (1)

Assay IDTitleYearJournalArticle
AID1070523Partition coefficient, log K of the compound in n-hexane/methyl tert-butylether/acetonitrile 10:1:10 solvent system by HSCCC/EECCC analysis2014Journal of natural products, Mar-28, Volume: 77, Issue:3
Airborne antituberculosis activity of Eucalyptus citriodora essential oil.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (18)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's1 (5.56)18.2507
2000's6 (33.33)29.6817
2010's8 (44.44)24.3611
2020's3 (16.67)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (5.56%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other17 (94.44%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]